WHWK
Whitehawk Therapeutics, Inc.
Key Financials
Operating Income
$-114400000
↓ 69.6%
Revenue
$7.1M
↓ 72.5%
Net Income
$-20596000
↑ 67.7%
Total Assets
$150.8M
↑ 114.5%
Total Liabilities
$14.5M
↓ 18.6%
EPS (Diluted)
$-0.33
↑ 86.0%
Shareholders' Equity
$136.3M
↑ 159.7%
Cash & Equivalents
$37.6M
↑ 31.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| SCHEDULE 13D/A | 5/18/2026 | View on SEC |
| SCHEDULE 13D/A | 5/14/2026 | View on SEC |
| 4 | 5/14/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | WHWK |
| Company Name | Whitehawk Therapeutics, Inc. |
| CIK | 1422142 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 551-321-2234 |